[1] [1] E. Ruoslahti, "How cancer spreads," Sci. Amer. 275, 72-77 (1996).

[2] [2] L. Weiss, "Metastatic inefficiency," Adv. Cancer Res. 54, 159-211 (1990).

[3] [3] C. W. Wong, A. Lee, L. Shientag, J. Yu, Y. Dong, G. Kao, A. B. Al-Mehdi, E. J. Bernhard, R. J. Muschel, "Apoptosis: An early event in metastatic inefficiency," Cancer Res. 61, 333-338 (2001).

[4] [4] J. E. Damber, G. Aus, "Prostate cancer," Lancet 371, 1710-1721 (2008).

[5] [5] A. W. Hsing, A. P. Chokkalingam, "Prostate cancer epidemiology," Front. Biosci. 11, 1388-1413 (2006).

[6] [6] A. Sica, V. Bronte, "Altered macrophage differentiation and immune dysfunction in tumor development," J. Clin. Invest. 117, 1155-1166 (2007).

[7] [7] S. J. Oosterling, G. J. V. D. Bij, G. A. Meijer, C. W. Tuk, E. V. Rooijen, N. V. Rooijen, S. Meijer, J. R. V. D. Sijp, R. H. Beelen, M. V. Egmond, "Macrophages direct tumour histology and clinical outcome in a colon cancer model," J. Pathol. 207, 147-155 (2005).

[8] [8] G. Heuff, H. S. Oldenburg, H. Boutkan, J. J. Visser, R. H. Beelen, N. V. Rooijen, C. D. Dijkstra, S. Meyer, "Enhanced tumour growth in the rat liver after selective elimination of Kupffer cells," Cancer Immunol. Immunother. 37, 125-130 (1993).

[9] [9] L. G. Bayon, M. A. Izquierdo, I. Sirovich, N. V. Rooijen, R. H. Beelen, S. Meijer, "Role of Kupffer cells in arresting circulating tumor cells and controlling metastatic growth in the liver," Hepatology 23, 1224-1231 (1996).

[10] [10] J. Condeelis, J. W. Pollard, "Macrophages: Obligate partners for tumor cell migration, invasion, and metastasis," Cell 124, 263-266 (2006).

[11] [11] J. Y. Shih, A. Yuan, J. J. W. Chen, P. C. Yang, "Tumor-associated macrophage: Its role in cancer invasion and metastasis," J. Cancer Molec. 2, 101-106 (2006).

[12] [12] E. Y. Lin, A. V. Nguyen, R. G. Russell, J. W. Pollard, "Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy," J. Exp. Med. 193, 727-740 (2001).

[13] [13] I. F. Lissbrant, P. Stattin, P. Wikstrom, J. E. Damber, L. Egevad, A. Bergh, "Tumor associated macrophages in human prostate cancer: Relation to clinicopathological variables and survival," Int. J. Oncol. 17, 445-451 (2000).

[14] [14] P. Seiler, P. Aichele, B. Odermatt, H. Hengartner, R. M. Zinkernagel, R. A. Schwendener, "Crucial role of marginal zone macrophages and marginal zone metallophils in the clearance of lymphocytic choriomeningitis virus infection," Eur. J. Immunol. 27, 2626-2633 (1997).

[15] [15] J. W. Tyner, O. Uchida, N. Kajiwara, E. Y. Kim, A. C. Patel, M. P. O'Sullivan, M. J. Walter, R. A. Schwendener, D. N. Cook, T. M. Danoff, M. J. Holtzman, "CCL5/CCR5 interaction provides anti-apoptotic signals for macrophage survival during viral infection," Nat. Med. 11, 1180-1187 (2005).

[16] [16] N. V. Rooijen, A. M. Sanders, T. K. V. D. Berg, "Apoptosis of macrophages induced by liposomemediated intracellular delivery of clodronate and propamidine," J. Immunol. Methods 193, 93-99 (1996).

[17] [17] N. V. Rooijen, A. Sanders, "Liposomes mediated depletion of macrophages: Mechanism of action, preparation of liposomes and applications," J. Immunol. Methods 174, 83-93 (1994).

[18] [18] N. V. Rooijen, J. Bakker, A. Sanders, "Transient suppression of macrophage functions by liposomeencapsulated drugs," Trends Biotechnol. 15, 178-185 (1997).

[19] [19] J. Novak, I. Georgakoudi, X. Wei, A. Prossin, C. P. Lin, "In vivo flow cytometer for realtime detection and quantification of circulating cells," Opt. Lett. 29, 77-79 (2004).

[20] [20] I. Georgakoudi, N. Solban, J. Novak, W. L. Rice, X. Wei, T. Hasan, C. P. Lin, "In vivo flow cytometry: A new method for enumerating circulating cancer cells," Cancer Res. 64, 5044-5047 (2004).

[21] [21] S. Boutrus, C. Greiner, D. Hwu, M. Chan, C. Kuperwasser, C. P. Lin, I. Georgakoudi, "Portable two-color in vivo flow cytometer for real-time detection of fluorescently-labelled circulating cells," J. Biomed. Opt. 12, 020507-1-020507-3 (2007).

[22] [22] D. A. Sipkins, X. Wei, J. W. Wu, J. M. Runnels, D. Cote, T. K. Means, A. D. Luster, D. T. Scadden, C. P. Lin, "In vivo imaging of specialized bone marrow endothelial microdomains for tumor engraftment," Nature 435, 969-973 (2005).

[23] [23] W. He, H. F. Wang, L. C. Hartmann, J. X. Cheng, P. S. Low, "In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry," Proc. Natl. Acad. Sci. USA 104, 11,760-11,765 (2007).

[24] [24] Y. Li, J. Guo, C. Wang, Z. Fan, G. Liu, C. Wang, Z. Gu, D. Damm, A. Mosig, X. Wei, "Circulation times of prostate cancer and hepatocellular carcinoma cells by in vivo flow cytometry," Cytometry A 79, 848-854 (2011).

[25] [25] V. V. Tuchin, A. Tarnok, V. P. Zharov, "In vivo flow cytometry: A horizon of opportunities," Cytometry A 79, 737-745 (2011).

[26] [26] C. M. Pitsillides, J. M. Runnels, J. A. Spencer, L. Zhi, M. X. Wu, C. P. Lin, "Cell labeling approaches for fluorescence-based in vivo flow cytometry," Cytometry A 79, 758-765 (2011).

[27] [27] Z. C. Fan, Y. Jun, G. D. Liu, X. Y. Tan, X. F. Weng, W. Z. Wu, J. Zhou, X. B. Wei, "Real-time monitoring of rare circulating hepatocellular carcinoma cells in an orthotopic model by in vivo flow cytometry assesses resection on metastasis," Cancer Res. 72, 2683-2691 (2012).

[28] [28] M.Yin, S. Li, L.Yuan, H.Dai, "Separation, cultivation and identification of mouse peritoneal macrophages," Med. J. Wuhan University 27, 203-205 (2006).

[29] [29] K. H. V. D. Hoek, S. Maddocks, C. M. Woodhouse, N. V. Rooijen, S. A. Robertson, R. J. Norman, "Intrabursal injection of clodronate liposomes causes macrophage depletion and inhibits ovulation in the mouse ovary," Biol. Reprod. 62, 1059-1066 (2000).

[30] [30] N. V. Rooijen, N. Kors, G. Kraal, "Macrophage subset repopulation in the spleen: Differential kinetics after liposome-mediated elimination," J. Leukoc. Biol. 45, 97-104 (1989).

[31] [31] M. B. Jordan, N. V. Rooijen, S. Izui, J. Kappler, P. Marrack, "Liposomal clodronate as a novel agent for treating autoimmune hemolytic anemia in a mouse model," Blood 101, 594-601 (2003).

[32] [32] S. J. Huh, S. Liang, A. Sharma, C. Dong, G. P. Robertson, "Transiently entrapped circulating tumor cells interact with neutrophils to facilitate lung metastasis development," Cancer Res. 70, 6071-6082 (2010).

[33] [33] A. E. Koch, P. J. Polverini, S. L. Kunkel, L. A. Harlow, L. A. DiPietro, V. M. Elner, S. G. Elner, R. M. Strieter, "Interleukin-8 as a macrophage-derived mediator of angiogenesis," Science 258, 1798-1801 (1992).

[34] [34] J. J. Chen, P. L. Yao, A. Yuan, T. M. Hong, C. T. Shun, M. L. Kuo, Y. C. Lee, P. C. Yang, "Upregulation of tumor interleukin-8 expression by infiltrating macrophages: Its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer," Clin. Cancer Res. 9, 729-737 (2003).